+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 279 Pages
  • Global
From
Hepatitis A Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis A Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 282 Pages
  • Global
From
Malaria Vaccines - Global Strategic Business Report - Product Thumbnail Image

Malaria Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 371 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 391 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Thumbnail Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • July 2025
  • 265 Pages
  • Global
From
Polio Vaccines - Global Strategic Business Report - Product Thumbnail Image

Polio Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 277 Pages
  • Global
From
Rabies Vaccine - Global Strategic Business Report - Product Thumbnail Image

Rabies Vaccine - Global Strategic Business Report

  • Report
  • July 2025
  • 467 Pages
  • Global
From
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 468 Pages
  • Global
From
Ebola Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Virus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 336 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Pneumococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pneumococcal Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 285 Pages
  • Global
From
From
Cholera Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 367 Pages
  • Global
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 182 Pages
  • Global
From
Conjugate Vaccines - Global Strategic Business Report - Product Thumbnail Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 271 Pages
  • Global
From
Shingles Vaccines - Global Strategic Business Report - Product Thumbnail Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 269 Pages
  • Global
From
Gout Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gout Disease Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 473 Pages
  • Global
From
From
Loading Indicator